Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Apr 17, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Revance Therapeutics, Inc.
-2.39K
$3.80
-$9,096.30
-2.04%
114.86K
Apr 16
Revance Therapeutics, Inc.
-12.18K
$5.11
-$62,186.40
-6.78%
167.55K
Mar 15 - Mar 18
Revance Therapeutics, Inc.
-11.39K
$5.12
-$58,313.17
-7.64%
137.81K
Mar 15 - Mar 18
Revance Therapeutics, Inc.
-13.18K
$5.12
-$67,479.49
-6.40%
192.67K
Mar 15 - Mar 18
Revance Therapeutics, Inc.
-20.53K
$5.31
-$108,927.56
-2.02%
994.93K
Mar 15
Revance Therapeutics, Inc.
30K
$6.98
$209,400.00
+3.04%
1.02M
Mar 6
Revance Therapeutics, Inc.
22.11K
—
—
+14.03%
179.73K
Feb 29
Revance Therapeutics, Inc.
15.14K
—
—
+11.30%
149.21K
Feb 29
Revance Therapeutics, Inc.
17.45K
—
—
+9.26%
205.85K
Feb 29
Revance Therapeutics, Inc.
70.75K
—
—
+7.73%
985.47K
Feb 29
Revance Therapeutics, Inc.
0
—
—
—
0
Revance Therapeutics, Inc.
0
—
—
—
0
Revance Therapeutics, Inc.
90K
—
—
+204.24%
134.07K
+1
Jan 31
Revance Therapeutics, Inc.
96.67K
—
—
+105.38%
188.4K
Jan 31
Revance Therapeutics, Inc.
0
—
—
—
0
Jan 31
Revance Therapeutics, Inc.
264
$7.47
$1,972.08
+0.17%
157.62K
Dec 31
Revance Therapeutics, Inc.
434
$7.47
$3,241.98
+0.48%
91.73K
Dec 31
Revance Therapeutics, Inc.
264
$7.47
$1,972.08
+0.03%
914.72K
Dec 31
Revance Therapeutics, Inc.
-4.71K
$8.08
-$38,072.96
-2.91%
157.35K
Dec 15
Revance Therapeutics, Inc.
-34.85K
$17.58
-$612,623.73
-44.16%
44.07K
+1
Sep 5 - Sep 6
Revance Therapeutics, Inc.
11.4K
$18.91
-$212,075.65
+14.27%
91.3K
Aug 11
Revance Therapeutics, Inc.
9.75K
$18.91
-$181,384.72
+14.10%
78.92K
+1
Aug 11
Revance Therapeutics, Inc.
13.72K
$18.91
-$168,317.91
+9.25%
162.07K
Aug 11
Revance Therapeutics, Inc.
74.08K
$18.91
-$908,890.24
+8.81%
914.45K
Aug 11
Revance Therapeutics, Inc.
-26.28K
$22.57
-$593,151.19
-3.03%
840.38K
Aug 3
Revance Therapeutics, Inc.
-932.00
$20.33
-$30,592.03
-1.15%
79.9K
Jun 30 - Jul 3
Revance Therapeutics, Inc.
1K
$15.61
$15,606.00
+0.68%
148.35K
Jun 30
Revance Therapeutics, Inc.
-25.28K
$20.27
-$639,726.56
-2.83%
866.65K
Jun 30 - Jul 3
Revance Therapeutics, Inc.
0
$23.18
-$25,300.00
—
16.56K
Jun 15
Revance Therapeutics, Inc.
-5.00K
$30.82
-$154,096.00
-3.28%
147.35K
Jun 9
Revance Therapeutics, Inc.
-31.28K
$30.72
-$960,928.41
-3.39%
891.93K
Jun 9
Revance Therapeutics, Inc.
-3.20K
$30.64
-$98,069.57
-3.81%
80.83K
Jun 1 - Jun 2
Revance Therapeutics, Inc.
20.95K
$34.55
-$739,338.21
+43.45%
69.17K
+1
Feb 2 - May 15
Revance Therapeutics, Inc.
20.95K
$34.55
-$739,338.21
+33.21%
84.03K
Feb 2 - May 15
Revance Therapeutics, Inc.
105.2K
$34.55
-$2,433,725.46
+12.86%
923.21K
Feb 2 - May 15
Revance Therapeutics, Inc.
31.38K
$34.55
-$726,003.10
+25.94%
152.35K
Feb 2 - May 15
Revance Therapeutics, Inc.
3.53K
—
—
+13.30%
30.11K
May 3
Revance Therapeutics, Inc.
3.53K
—
—
+26.89%
16.68K
May 3
Revance Therapeutics, Inc.
3.53K
—
—
+14.10%
28.61K
May 3
Revance Therapeutics, Inc.
3.53K
—
—
+27.13%
16.56K
May 3

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.